A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adolescents

Clinical trial NCT04951388 · COMPLETED

Trial details

NCT number: NCT04951388
Sponsor: Medigen Vaccine Biologics Corp.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Covid19 Vaccine

Start date: 2021-07-22
Primary completion: 2021-10-25
Enrollment: 399

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.